Wolff A, Joshi RK, Ekström J, Aframian D, Pedersen AM, Proctor G, et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D. 2017;17(1):1–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomson WM, Ferguson CA, Janssens BE, Kerse NM, Ting GS, Smith MB. Xerostomia and polypharmacy among dependent older New Zealanders: a national survey. Age Ageing. 2021;50(1):248–51.

Article  PubMed  Google Scholar 

Villa A, Wolff A, Aframian D, Vissink A, Ekström J, Proctor G, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig. 2015;19(7):1563–80.

Article  PubMed  Google Scholar 

Scully C. Drug effects on salivary glands: dry mouth. Oral Dis. 2003;9(4):165–76.

Article  CAS  PubMed  Google Scholar 

Närhi TO, Meurman JH, Ainamo A. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging. 1999;15(2):103–16.

Article  PubMed  Google Scholar 

Turner MD. Hyposalivation and xerostomia: etiology, complications, and medical management. Dent Clin N Am. 2016;60(2):435–43.

Article  PubMed  Google Scholar 

Nadig SD, Ashwathappa DT, Manjunath M, Krishna S, Annaji AG, Shivaprakash PK. A relationship between salivary flow rates and Candida counts in patients with xerostomia. J Oral Maxillofac Pathol. 2017;21(2):316.

Article  PubMed  PubMed Central  Google Scholar 

Solemdal K, Sandvik L, Willumsen T, Mowe M, Hummel T. The impact of oral health on taste ability in acutely hospitalized elderly. PLoS One. 2012;7(5):e36557.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ikebe K, Matsuda K, Morii K, Furuya-Yoshinaka M, Nokubi T, Renner RP. Association of masticatory performance with age, posterior occlusal contacts, occlusal force, and salivary flow in older adults. Int J Prosthodont. 2006;19(5):475–81.

PubMed  Google Scholar 

Poisson P, Laffond T, Campos S, Dupuis V, Bourdel-Marchasson I. Relationships between oral health, dysphagia and undernutrition in hospitalised elderly patients. Gerodontology. 2016;33(2):161–8.

Article  PubMed  Google Scholar 

van der Putten GJ, Brand HS, Schols JM, de Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig. 2011;15(2):185–92.

Article  PubMed  Google Scholar 

Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15(6):753–68.

Article  CAS  PubMed  Google Scholar 

Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging. 1993;3(4):335–48.

Article  CAS  PubMed  Google Scholar 

Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93(9):457–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221(2):555–63.

Article  CAS  PubMed  Google Scholar 

Marcum ZA, Perera S, Thorpe JM, Switzer GE, Gray SL, Castle NG, et al. Anticholinergic use and recurrent falls in community-dwelling older adults: findings from the health ABC Study. Ann Pharmacother. 2015;49(11):1214–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–7.

Article  PubMed  PubMed Central  Google Scholar 

Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc. 2011;59(8):1477–83.

Article  PubMed  Google Scholar 

Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–13.

Article  PubMed  Google Scholar 

Kersten H, Molden E, Willumsen T, Engedal K, Bruun Wyller T. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. Br J Clin Pharmacol. 2013;75(3):842–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lavrador M, Cabral AC, Figueiredo IV, Veríssimo MT, Castel-Branco MM, Fernandez-Llimos F. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients. Int J Clin Pharm. 2021;43(1):128–36.

Article  CAS  PubMed  Google Scholar 

Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2013;68(3):271–8.

Article  CAS  PubMed  Google Scholar 

Nederfors T, Isaksson R, Mörnstad H, Dahlöf C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population--relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol. 1997;25(3):211–6.

Article  CAS  PubMed  Google Scholar 

Johansson AK, Johansson A, Unell L, Ekbäck G, Ordell S, Carlsson GE. Self-reported dry mouth in 50- to 80-year-old Swedes: longitudinal and cross-sectional population studies. J Oral Rehabil. 2020;47(2):246–54.

Article  PubMed  Google Scholar 

Ohara Y, Hirano H, Yoshida H, Obuchi S, Ihara K, Fujiwara Y, et al. Prevalence and factors associated with xerostomia and hyposalivation among community-dwelling older people in Japan. Gerodontology. 2016;33(1):20–7.

Article  PubMed  Google Scholar 

Byrne CJ, Walsh C, Cahir C, Ryan C, Williams DJ, Bennett K. Anticholinergic and sedative drug burden in community-dwelling older people: a national database study. BMJ Open. 2018;8(7):e022500.

Article  PubMed  PubMed Central  Google Scholar 

Suehs BT, Caplan EO, Hayden J, Ng DB, Gaddy RR. The relationship between anticholinergic exposure and falls, fractures, and mortality in patients with overactive bladder. Drugs Aging. 2019;36(10):957–67.

Article  CAS  PubMed  Google Scholar 

Frigaard J, Hynne H, Jensen JL. Development and proposal of a novel scoring system to classify dry mouth severity. Appl Sci Basel. 2023;13(21):11758.

Article  CAS  Google Scholar 

Ringstad IB, Romskaug R, Santervas LR, Fjeld KG, Hove LH, Skovlund E, et al. Oral health, xerogenic medications, and frailty in acutely ill older adults. J Am Geriatr Soc. 2025.

King R, Rabino S. ACB calculator. 2025. https://www.acbcalc.com/.

Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. J Aging Health. 2008;4(3):311–20.

Article  CAS  Google Scholar 

Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr. 2018;18(1):239.

Article  PubMed  PubMed Central  Google Scholar 

Lisibach A, Benelli V, Ceppi MG, Waldner-Knogler K, Csajka C, Lutters M. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review. Eur J Clin Pharmacol. 2021;77(2):147–62.

Article  PubMed  Google Scholar